What's Your Bio Strategy? - Cumbers, John

. .

Résumé :
NAMED ONE OF LABIOTECH'S TOP 50 BIOTECH BOOKS OF ALL TIME and TOP 10 BIOTECH BOOKS. The last 50 years have been dominated by microprocessors and information technology. The next 50 will be defined by engineered living systems.Consumer packaged goods, energy, food, healthcare, and materials industries are being transformed by the digitization of biology, gene editing tools, and synthetic biology - the rapidly developing field of engineering biology.What's Your Bio Strategy? is a collection of interviews with the innovators like George Church (Harvard University), Andras Forgacs (Modern Meadow), Jason Kelly (Ginkgo Bioworks), Andrew Hessel (Autodesk), Suzanne Lee (Biofabricate), Pamela Silver (Harvard University), and J. Craig Venter describing the massive advances making biology easy and accessible. What tools and technologies are driving bio-fabrication, gene editing and synthetic biology? What industries are being disrupted today? How must your business prepare for engineered biology? What's Your Bio Strategy? includes a framework for incorporating engineered biology into your business. It is an excellent companion for strategic planners and executives who need to plan product development strategies.John Cumbers Ph.D., is the founder of SynBioBeta, the activity hub for synthetic biology startup companies, industry, and investors. Karl Schmieder M.S./M.F.A., is the founder of messagingLAB, a strategic marketing firm that works with life science leaders. PRAISE for What's Your Bio Strategy? We humans take much for granted, especially when we experience the benefits of science and technology without recognizing the massive improvement to our lives. There is nothing more important than life, and the ability to engineer biology is progressing to the point where the improvements will change life for the better-even more than they have already. Let Cumbers and Schmieder share the future of biotechnology-and life-now. - Anthony Iannarino, best-selling author, The Only Sales Guide You'll Ever Need and The Lost Art of Closing Today's revolutionary advances in biotechnology often feel more like science fiction then the real science they are. In What's Your Bio Strategy? Cumbers and Schmieder pull back the curtain on the biotechnologies being developed today and provide a framework to help businesses and individuals alike understand the implications and incorporate biotechnology into their work. - Jamie Metzl, author, Eternal Sonata and Genesis Code Biotech can be pretty intimidating subject to newcomers. 'What's Your Bio Strategy' is a great place to start learning about what the science is enabling, and where it's heading. - Luke Timmerman, founder and editor, Timmerman Report...

Biographie:
John Cumbers Ph.D., is the founder of SynBioBeta , an activity hub for synthetic biology startup companies, industry and investors. He is an operating partner at DCVC and runs the DCVC SynBioBeta fund which invests in seed and pre-seed stage companies. He received his Ph.D., in Molecular Biology, Cell Biology, and Biochemistry from Brown University. John holds a masters degree in bioinformatics from the University of Edinburgh in Scotland and an undergraduate degree in computer science from the University of Hull in England. In 2005, he founded the iGEM (International Genetically Engineered Machines competition) team at Brown University, was an iGEM ambassador to China in 2006/2007, and worked at NASA for 7 years in the field of synthetic biology and resource utilization in space. At NASA he led partnerships to bring new technologies to bear on sustainability challenges on Earth and in space. In 2010, John was the recipient of a National Academies Keck Futures Initiative award to hold a workshop on the role that synthetic biology could play in NASA's missions. Find John on LinkedIn, SynBioBeta, and Twitter as @johncumbers.

Sommaire:
author, Hood: Trailblazer of the Genomics Age With the title, What's Your Bio Strategy? you might believe this book only applies to biopharmaceutical companies. But you'd be wrong. Reading Cumbers' and Schmieder's interviews of 25 innovators, you realize that nearly every industry faces disruption by biotech, and companies lacking a strategy for how to soon implement bio at their organizations aren't likely to survive. - Rob Wright, chief editor, Life Science Leader magazine...